Search

everythinglearnresearchcommunity

for

Search:↓

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

These ovarian conditions cause high testosterone levels.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Serum triglyceride levels are not linked to prostate cancer risk.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

New methods for growing skin cells can improve skin grafts by building blood vessels within them.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some men with early hair loss may have a condition similar to PCOS in women.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.